Concepedia
5
Publications
125
Citations
H-Index
2016
Active since
Affiliations
Dana-Farber Cancer Institute(Current)
Massachusetts General Hospital
Broad Institute
Harvard University
Brigham and Women's Hospital
Ishwarya Murali is an author at Dana-Farber Cancer Institute.
Publications per year
2016–2023
Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemia
Ishwarya Murali, Siddha Kasar, Aishath Naeem et al. · Blood · 2021 · 60 citations · Full text
Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples
Jasneet Kaur Khalsa, Justin Cha, Filippo Utro et al. · Blood · 2023 · 24 citations · Full text
The effect of chronic alcohol consumption on mitochondrial calcium handling in hepatocytes
Guoqiang Wang, Elisabeth Mémin, Ishwarya Murali et al. · Biochemical Journal · 2016 · 17 citations
Activating MAPK Pathway Mutations Mediate Primary Resistance to PI3K Inhibitors in Chronic Lymphocytic Leukemia (CLL)
Ishwarya Murali, Siddha Kasar, Emily M. McWilliams et al. · Blood · 2018 · 13 citations
Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia
Yanping Yin, Paschalis Athanasiadis, Linda Karlsen et al. · Clinical Cancer Research · 2022 · 11 citations · Full text
Rows per page
1–5 of 5